DGIdb - MASUPIRDINE Drug Record

MASUPIRDINE chembl:CHEMBL4117187

Alternate Names:

SUVN-502
MASUPIRDINE

Drug Info:

FDA Approval	not approved
Drug Class	small molecule
Drug Indications	for treatment of Alzheimer's disease
Drug Type	small molecule
Drug Groups	investigational
Drug Categories	heterocyclic compounds, fused-ring
Drug Categories	neurotransmitter agents

(0 More Sources)

Publications:

Nirogi RV et al., 2010, Novel and Potent 5-Piperazinyl Methyl-N 1-aryl Sulfonyl Indole Derivatives as 5-HT6 Receptor Ligands., ACS Med Chem Lett

MASUPIRDINE HTR6

Interaction Score: 4.46

Interaction Types & Directionality:

n/a

Interaction Info:

Trial Name SUVN-502

Novel drug target Established target

PMIDs:
24900216

Sources:
TdgClinicalTrial TTD DrugBank

DrugBank: DB06140
- Version: 5.1.7
Alternate Names:

SUVN-502 DrugBank Drug Name

701205-60-9 CAS Number

CHEMBL4117187 ChEMBL ID

Drug Info:

Drug Type small molecule

Drug Groups investigational

Drug Categories heterocyclic compounds, fused-ring

Publications:
TdgClinicalTrial: SUVN-502
- Version: January-2014
Alternate Names:

Drug Info:

Drug Indications for treatment of Alzheimer's disease

Drug Class small molecule

FDA Approval not approved

Publications:
TTD: SUVN-502
- Version: 2020.06.01
Alternate Names:

D0Z0GX TTD Drug ID

Drug Info:

Publications:

Nirogi RV et al., 2010, Novel and Potent 5-Piperazinyl Methyl-N 1-aryl Sulfonyl Indole Derivatives as 5-HT6 Receptor Ligands., ACS Med Chem Lett
ChemblDrugs: chembl:CHEMBL4117187
- Version: ChEMBL_27
Alternate Names:

Drug Info:

Publications: